PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Kenneth R Cooke Selected Research

Pneumonia (Pneumonitis)

10/2008	The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.
04/2008	A role for TNF receptor type II in leukocyte infiltration into the lung during experimental idiopathic pneumonia syndrome.
03/2005	Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation.
03/2005	A role for CD54 (intercellular adhesion molecule-1) in leukocyte recruitment to the lung during the development of experimental idiopathic pneumonia syndrome.
08/2004	A role for tumor necrosis factor-alpha-mediated endothelial apoptosis in the development of experimental idiopathic pneumonia syndrome.
08/2004	Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome.
07/2004	Donor-derived TNF-alpha regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation.
03/2004	A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation.
01/2002	Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.

Articles by Research Topic

Disease

10	Syndrome 10/2008 - 01/2002
9	Pneumonia (Pneumonitis) 10/2008 - 01/2002
9	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2008 - 03/2002
3	Leukemia 09/2003 - 11/2002
1	Hemolysis 04/2008
1	Bronchiolitis Obliterans 07/2007
1	Cryptogenic Organizing Pneumonia (BOOP) 07/2007
1	Adult Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2005

Drug/Important Bio-Agent (IBA)

3	TNFR-Fc fusion protein (etanercept)FDA Link 10/2008 - 01/2002
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007 - 07/2004
2	Chemokine CCL5IBA 11/2007 - 03/2005
2	Interleukin-18 (Interleukin 18)IBA 04/2003 - 11/2002
1	Interleukin-13IBA 04/2008
1	alemtuzumab (Campath)FDA Link 04/2008
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 04/2008
1	Methylprednisolone FDA LinkGeneric 09/2005
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2005
1	CXCR3 ReceptorsIBA 08/2004
1	Heme Oxygenase-1IBA 07/2004
1	Fibroblast Growth Factor 10IBA 09/2003
1	PerforinIBA 11/2002
1	Isoantigens (Alloantigen)IBA 06/2002
1	flt3 ligand protein (flt3 ligand)IBA 03/2002

Therapy/Procedure

5	Transplants (Transplant) 04/2008 - 03/2002
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2008 - 11/2002
3	Hematopoietic Stem Cell Transplantation 10/2008 - 01/2002
3	Stem Cell Transplantation 11/2007 - 03/2005